Saoudi González, N.; Ros, J.; Baraibar, I.; Salvà, F.; Rodríguez-Castells, M.; Alcaraz, A.; García, A.; Tabernero, J.; Élez, E.
Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer. Cancers 2024, 16, 412.
https://doi.org/10.3390/cancers16020412
AMA Style
Saoudi González N, Ros J, Baraibar I, Salvà F, Rodríguez-Castells M, Alcaraz A, García A, Tabernero J, Élez E.
Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer. Cancers. 2024; 16(2):412.
https://doi.org/10.3390/cancers16020412
Chicago/Turabian Style
Saoudi González, Nadia, Javier Ros, Iosune Baraibar, Francesc Salvà, Marta Rodríguez-Castells, Adriana Alcaraz, Ariadna García, Josep Tabernero, and Elena Élez.
2024. "Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer" Cancers 16, no. 2: 412.
https://doi.org/10.3390/cancers16020412
APA Style
Saoudi González, N., Ros, J., Baraibar, I., Salvà, F., Rodríguez-Castells, M., Alcaraz, A., García, A., Tabernero, J., & Élez, E.
(2024). Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer. Cancers, 16(2), 412.
https://doi.org/10.3390/cancers16020412
